Educational research only—not investment advice or a recommendation. Scores and estimates may use delayed, incomplete, restated, or corrected market and filing data. Independently verify information before making an investment decision.

iTonic Holdings Ltd.

ITOCNASDAQ

Wall Street Score · overall investment33/100

$0.25USD$-0.04 (-12.88%)

Severe listing-compliance risk

The share price is below $1 and the stored reverse-split/listing-risk level is CRITICAL. No verified reverse-split authorization or announced reverse split is currently recorded. This is a risk signal, not confirmation that Nasdaq has issued a deficiency notice.

Company website www.ftzy.com.cn

HeadquartersNET Building, Room 306, Hong Jun Ying South Road, Beijing, BE, 100101, CN

Financial statement currencyUSD · no FX conversion applied

Healthcare · Medical - Specialties

WatchlistExport PDF Alerts

Price updated todayFinancials updated Oct 1, 2026

Price Chart$-0.05 (-15.54%)

Advanced Chart

Company & revenue

About iTonic Holdings Ltd.

Who they are

iTonic Holdings Ltd., a healthcare solutions firm, specializes in the development and commercialization of software and devices for brachytherapy. Its advanced proprietary treatment planning system centers on radioactive particle implantation, a form of radiotherapy employed in cancer treatment to precisely position radioactive sources within patients, thereby eradicating malignant cells and reducing tumor size. Key among its offerings is FTTPS, a sophisticated treatment planning system engineered for diverse malignant tumors.

Detailed revenue, brand and relationship research has not yet been completed for ITOC.

Wall Street Score

Overall investment score · Quality, value, risk and opportunity

Poor

PoorElite

View category scores →

Company Quality

How good is the actual business—regardless of today’s stock price?

Weak

Financial Strength

Business Quality / Moat

Management

Growth Quality

100

Risk / Durability

Weak Company · Expensive Stock

Uses financial strength, moat, management, growth quality and durability. It excludes share price, P/E, market cap, intrinsic value and margin of safety.

Model Outlook

12-month model · What does the model think happens next?

Outperformance analysis is not currently available.

Reverse-split / listing-compliance risk: CRITICAL

This is a risk signal, not a prediction. It is separate from Wall Street Score and does not change the company score. It looks for listing-pressure signals such as prolonged Nasdaq trading below $1, very low share price, micro-cap size, negative free cash flow, and verified recent reverse splits.

Risk indicator: 75/100

WSS View

The quick read

WSS currently sees meaningful weaknesses in the company-strength profile.

A current Opportunity Score is not available.

The 12-month model outlook is not currently available.

What we like

•Balance-sheet / debt profile scores strongly
•Asset quality scores strongly

What to watch

•Reverse-split headline · Oct 2, 2026
•Valuation is a weaker part of the current profile
•Revenue fundamentals are weak

Company-specific research

Questions worth answering for ITOC

Research inputs 100% complete

These questions are generated from this company's current financial and score data so the page adds context instead of treating the headline score as a stand-alone conclusion.

•Can ITOC maintain its current revenue growth rate and improve the amount of that revenue that turns into earnings and cash?
•How long can ITOC fund negative free cash flow using its current cash position before it may need more debt or new shares?
•How is ITOC likely to use its cash advantage: reinvestment, acquisitions, debt reduction, dividends or buybacks?
•What specifically needs to improve for ITOC to reach sustainable profitability?
•What future growth or profitability would be needed to justify ITOC's current valuation?

⚠ 1 warningView warning details

Reverse-split headline · Oct 2, 2026

Business analysis: 29 days ago · Fresh

Essential Investment Snapshot

Wall Street Score

0–100 · Poor

Market Cap

$2.3M

P/E Ratio

-0.8

EPS

$-0.37

52-Week High

$1.15

52-Week Low

$0.22

Beta

2.77

Shares Outstanding

16.0M

Total Revenue

$971K

Total Debt

$143K

Dividend

No current dividend

View dividend history

Liquidation Value / Share

$0.51

Estimated net asset value per share

Momentum & Volatility Signals

Two different market-behavior signals. Momentum measures direction and trend strength. Volatility measures how large and unstable the price moves are, regardless of direction.

0–100 market signals

Momentum

15/ 100

-15 pts / 5d

Strong downward momentum

5D -14.4% · 20D -15.5% · RSI 38 · Price vs 20D avg -16.7%

Volatility

71/ 100

+15 pts / 5d

High movement

20D realized vol 81.1% · 60D 80.6% · Acceleration 1.01x

Momentum = Where is it going?

A high momentum score means price has been trending upward with confirming short- and medium-term strength. A low score means downward or weakening momentum.

Volatility = How violently is it moving?

A high volatility score means larger, less stable price swings. It can happen while a stock is rising or falling, so high volatility is not automatically bullish or bearish.

Important: the volatility score above is based on realized price volatility. Implied volatility (IV) comes from options prices and represents the market's expected future movement. Wall Street Score will keep IV separate and will only display it when a verified options-chain feed is available.

Notices for ITOC

Detected from reported data — verify before acting.

Reverse-split headline · Oct 2, 2026

iTonic Holdings Ltd Announces 16-for-1 Share Consolidation Effective October 6, 2026 — This is a provider-linked headline, not an independently confirmed event. Check the article and company filings for the subject, proposed/completed status, and subsequent updates.

GlobeNewsWire

Community Sentiment

0 active · 0 total calls

0% Bullish (0) 0% Bearish (0)

No personal call yet on ITOC.

What the Bulls Say

+Growth opportunities may come from revenue expansion, margin improvement, new products, market-share gains, and stronger cash flow.
+Product opportunity: iTonic Holdings Ltd., a healthcare solutions firm, specializes in the development and commercialization of software and devices for brachytherapy. Its advanced proprietary treatment planning system centers on radioactive particle implantation, a form of radiotherapy employed in cancer treatment to precisely position radioactive sources within patients, thereby eradicating malignant cells and reducing tumor size. Key among its offerings is FTTPS, a sophisticated treatment planning system engineer.

What the Bears Say

−Key risks may include competition, margin pressure, debt levels, valuation risk, and changes in demand within the Medical - Specialties industry.
−Diluted weighted-average shares increased 15.9% year over year.
−Negative free cash flow may increase the need for outside financing and dilution.

Bull and bear cases summarize disclosed catalysts, growth opportunities and risks; they are not buy or sell recommendations.

Create a free account to make a call.

Scores

Click any score for full breakdown

Wall Street Score

Weak33/ 100

Weak (0–50)Fair (51–71)Strong (72+)

Poor

Tap for breakdown →

Strong

Debt Cost—

Debt Reduction YoY42.3%

Debt / Equity0.02x

Tap for breakdown →

Poor

Revenue YoY85.7%

Revenue CAGR-8.8%

Net Margin-5.9%

Tap for breakdown →

Elite

100

Asset Growth YoY35.3%

Liquidation/Share$0.51

Net Assets/MCap3.41x

Tap for breakdown →

Poor

Earnings Yield-2.2%

Buyback Yield0.0%

Debt Cost—

Tap for breakdown →

Weak

ROIC-1.1%

ROE-94.0%

ROA-63.3%

Tap for breakdown →

Poor

EPS Growth—

FCF/Share Growth—

Rev/Share Growth-9.4%

Tap for breakdown →

Poor

Your privacy choices

iTonic Holdings Ltd.

About iTonic Holdings Ltd.

The quick read

Questions worth answering for ITOC

Essential Investment Snapshot

Momentum & Volatility Signals

Community Sentiment

What the Bulls Say

What the Bears Say

Scores

Score Changes

Price vs. Value

Related Companies

News

Related Stock Research

Score Alerts

Portfolio Score